The present study showed that targets of Chrysanthemum phytochemicals (luteolin, chlorogenic acid, rutin, quercetin, and apigenin) belong to estrogen receptors such as ESR1, ESR2, and PGR and are major therapeutic targets of breast cancer. This evidence concerns the gene ESR2 and breast carcinoma.